疾病修饰性抗风湿药物对心脏沙尔科毒症患者的比较有效性
Lisbeth Brooks1, William Kivlin1,2, Divyanshu Mohananey1,2,3
1Medical College of Wisconsin, Milwaukee, WI, USA.
Rheumatology (Oxford, England)
|December 26, 2024
概括
甲托雷克萨特对型硬化症患者显示出有利的安全性,在预防心脏事件方面具有与甲酸或阿扎西奥普林相似的疗效. 由于感染风险较低,可能更喜欢用甲托雷克萨特.
科学领域:
- 类风湿病学 类风湿病学
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心脏型硬化症是型硬化症的严重表现.
- 修饰疾病的抗风湿药物 (DMARDs) 用于管理类麻症.
- 对DMARDs在心脏沙丘病症中的比较疗效和安全性数据有限.
研究的目的:
- 为了比较甲索特雷克萨特,mycophenolate mofetil和阿扎西奥普林在患有心脏沙丘病的患者中的疗效.
- 评估这些DMARDs在预防非心脏类型瘤患者心脏类型瘤发病的有效性.
- 评估与这些DMARD相关的安全概况,特别是感染风险.
主要方法:
- 使用美国TrinetX电子健康记录数据库 (2008-2023) 进行的回顾性队列研究.
- 包括新使用的甲基甲酸盐,甲基酸盐或阿扎西奥普林治疗沙丘病的患者.
- 对治疗的逆概率加权的Cox比例危险回归来比较结果.
主要成果:
- 在601名心脏沙丘病患者中,mycophenolate (HR 0.83) 和azathioprine (HR 0.74) 与methotrexate的结果相似.
- 在2840名非心脏类沙尔科发症患者中,心脏类沙尔科发症的风险与mycophenolate (HR 1.11) 和azathioprine (HR 0.54) 与methotrexate相比是相似的.
- 与甲醇相比,酸 (HR 1.83) 和阿扎西奥普林 (HR 1.32) 与感染风险增加有关.
结论:
- 甲托雷克萨特在感染风险方面表现出有利的安全性.
- 甲二甲酸可能比阿扎西奥普林或mycophenolate mofetil更好地用于沙尔科病症和心脏沙尔科病症的管理.
- 进一步的研究可能会探索长期的比较有效性和安全性.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
302
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
302
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
98
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
98
Heart Failure Drugs: Diuretics
275
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
275
Structure-Activity Relationships and Drug Design
420
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
420
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
384
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
384
Heart Failure Drugs: Inotropic Agents
398
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
398


